rs145007061
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001130987.2(DYSF):c.2147C>T(p.Ala716Val) variant causes a missense change. The variant allele was found at a frequency of 0.000156 in 1,574,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A716A) has been classified as Likely benign.
Frequency
Consequence
NM_001130987.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DYSF | NM_001130987.2 | c.2147C>T | p.Ala716Val | missense_variant | 22/56 | ENST00000410020.8 | |
DYSF | NM_003494.4 | c.2093C>T | p.Ala698Val | missense_variant | 22/55 | ENST00000258104.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DYSF | ENST00000410020.8 | c.2147C>T | p.Ala716Val | missense_variant | 22/56 | 1 | NM_001130987.2 | A1 | |
DYSF | ENST00000258104.8 | c.2093C>T | p.Ala698Val | missense_variant | 22/55 | 1 | NM_003494.4 | A1 |
Frequencies
GnomAD3 genomes ? AF: 0.000815 AC: 124AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000181 AC: 34AN: 187634Hom.: 0 AF XY: 0.000140 AC XY: 14AN XY: 99922
GnomAD4 exome AF: 0.0000858 AC: 122AN: 1421674Hom.: 0 Cov.: 32 AF XY: 0.0000882 AC XY: 62AN XY: 703116
GnomAD4 genome ? AF: 0.000814 AC: 124AN: 152326Hom.: 0 Cov.: 33 AF XY: 0.000833 AC XY: 62AN XY: 74474
ClinVar
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Dec 01, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 09, 2020 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 06, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Feb 27, 2019 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2B Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 23, 2020 | - - |
Qualitative or quantitative defects of dysferlin Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 28, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at